JOHANNESBURG (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.
It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine.
(Reporting by Alexander Winning; Editing by Christopher Cushing)
